SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-026416
Filing Date
2021-10-27
Accepted
2021-10-27 09:16:09
Documents
54
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 779812
2 ex31-1.htm EX-31.1 11944
3 ex31-2.htm EX-31.2 12166
4 ex32.htm EX-32 5906
5 form10-q_001.jpg GRAPHIC 6057
  Complete submission text file 0001493152-21-026416.txt   3337241

Data Files

Seq Description Document Type Size
6 INLINE XBRL INSTANCE DOCUMENT crxm-20200930.xml EX-101.INS 451296
7 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT crxm-20200930.xsd EX-101.SCH 33891
8 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT crxm-20200930_cal.xml EX-101.CAL 44668
9 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT crxm-20200930_def.xml EX-101.DEF 151695
10 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT crxm-20200930_lab.xml EX-101.LAB 260278
11 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT crxm-20200930_pre.xml EX-101.PRE 212643
Mailing Address 11750 SORRENTO VALLEY ROAD SUITE 250 SAN DIEGO CA 92121
Business Address 11750 SORRENTO VALLEY ROAD SUITE 250 SAN DIEGO CA 92121 (858) 436-1000
Gene Biotherapeutics, Inc. (Filer) CIK: 0000772320 (see all company filings)

IRS No.: 840635673 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33635 | Film No.: 211350971
SIC: 2836 Biological Products, (No Diagnostic Substances)